Reduction of childhood pneumonia mortality in the Sustainable Development era-Reference-Cited by-同舟云学术

Reduction of childhood pneumonia mortality in the Sustainable Development era

Published:2016-12 Issue:12 Volume:4 Page:932-933
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

McCollum Eric D,King Carina,Hammitt Laura L,Ginsburg Amy S,Colbourn Tim,Baqui Abdullah H,O'Brien Katherine L

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference12 articles.

1. Liu L, Oza S, Hogan D, et al. Global, regional and national causes of child mortality in 2000–2015—implications for the Sustainable Development Goals. Lancet (in press).

2. mHealth: An updated systematic review with a focus on HIV/AIDS and tuberculosis long term management using mobile phones;Devi;Comput Methods Programs Biomed,2015

3. mPneumonia: development of an innovative mhealth application for diagnosing and treating childhood pneumonia and other childhood illnesses in low-resource settings;Ginsburg;PLoS One,2015

4. Integrated Management of Childhood Illness: Chart Booklet,2014

5. The prevalence of hypoxaemia among ill children in developing countries: a systematic review;Subhi;Lancet Infect Dis,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the causative pathogen among children with pneumonia using a causal Bayesian network;PLOS Computational Biology;2023-03-13

2. Predicting the causative pathogen among children with pneumonia using a causal Bayesian network;2022-07-02

3. Identifying modifiable risk factors for mortality in children aged 1–59 months admitted with WHO-defined severe pneumonia: a single-centre observational cohort study from rural Malawi;BMJ Paediatrics Open;2022-04

4. Vitamin D supplementation among Bangladeshi children under-five years of age hospitalised for severe pneumonia: A randomised placebo controlled trial;PLOS ONE;2021-02-19

5. Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial;The Lancet Respiratory Medicine;2019-11